UPDATE : Monday, December 9, 2019
상단여백
Hanmi's Chinese partner to start trials for anticancer treatment
Hanmi Pharmaceutical said its Chinese partner Innovent Biologics has begun ...
by Lee Han-soo  |  2019-11-28 17:38
라인
GI Innovation licenses out immunotherapy drug candidate to Chinese firm
GI Innovation said that it has licensed out GI-101, a bispecific fusion pro...
by Lee Han-soo  |  2019-11-28 16:26
라인
Takeda's ovarian cancer drug Zejula to get insurance benefit
The government said it would grant insurance benefit to Takeda's ovaria...
by Lee Han-soo  |  2019-11-28 15:36
라인
ST Pharm submits IND application for colorectal cancer treatment in US
ST Pharm said that it has submitted an investigational new drug application...
by Lee Han-soo  |  2019-11-28 14:52
라인
New Parkinson’s drug Ongentys lands on Korea
SK Chemicals said Thursday it has won local marketing license for Ongentys ...
by Jeong Sae-im  |  2019-11-28 14:52
라인
Experts ascribe excessive diabetes hospitalization to lack of early treatment
Local diabetes experts on Wednesday stressed the need to treat diabetes at ...
by Lee Han-soo  |  2019-11-28 11:26
라인
Bristol-Myers Squibb Korea names new CEO
Bristol-Myers Squibb Korea said that it has appointed Kim Jin-young as the ...
by Lee Han-soo  |  2019-11-28 11:26
라인
SK Chemicals wins FDA nod for patch-type Alzheimer’s drug
SK Chemicals said it has obtained approval from the U.S. Food and Drug Admi...
by Jeong Sae-im  |  2019-11-27 18:24
라인
Daewoong ends P3 trial for drug treating gastroesophageal reflux disease
Daewoong Pharmaceutical said that it has completed the phase 3 clinical tri...
by Lee Han-soo  |  2019-11-27 18:21
라인
Vivozon stops short of meeting primary endpoint for P2b trial of nonnarcotic analgesics
Vivozon said that it has obtained good clinical results from the U.S. phase...
by Lee Han-soo  |  2019-11-26 18:48
라인
Amgen releases analysis result showing benefits of LDL-C treatment
Amgen Korea said it has presented the analysis of its high cholesterol (LDL...
by Lee Han-soo  |  2019-11-26 17:05
라인
Roche’s flu treatment Xofluza wins approval
A new influenza treatment has arrived in Korea in over 20 years.The Ministr...
by Kim Yun-mi  |  2019-11-26 16:08
라인
Immunotherapies give hope for esophageal cancer patients
In curing esophageal cancer, there has been no treatment option other than ...
by Kim Yun-mi  |  2019-11-26 15:37
라인
GC Labcell hands over NK cell-treating tech to US lab
GC Labcell said it has transferred its natural killer (NK) cell treatment t...
by Lee Han-soo  |  2019-11-26 15:33
라인
SK Biopharm to speed up global advance through XCOPRI’s launch
SK Biopharmaceuticals will launch its antiepileptic drug, XCOPRI, in the se...
by Lee Han-soo  |  2019-11-26 14:16
라인
Huons Global wins KGMP certification for BTX plant
Huons Global said that the Ministry of Food and Drug Safety has granted the...
by Lee Han-soo  |  2019-11-25 16:00
라인
Gtree enrolls 200 patients for US trial of dry eye treatment
ReGenTree, the U.S. subsidiary of Gtree BNT, said that it has managed to en...
by Lee Han-soo  |  2019-11-25 14:49
라인
Daewoong renews EU GMP certification for BTX plant
Daewoong Pharmaceutical said that it has renewed its EU good manufacturing ...
by Lee Han-soo  |  2019-11-25 11:55
라인
SK Biopharm's antiepileptic drug is 1st local medicine to win FDA nod independently
SK Biopharmaceuticals' XCOPRI, a treatment for partial-onset seizures i...
by Lee Han-soo  |  2019-11-22 17:03
라인
Bridge Biotherapeutics aims to become global NRDO company
Bridge Biotherapeutics revealed its goal to become Korea's top no resea...
by Lee Han-soo  |  2019-11-22 15:10
여백
여백
여백
Back to Top